OcuTerra Therapeutics’ investigational eye drops failed to improve disease severity or progression in a phase 2 diabetic retinopathy trial, prompting the Boston-based biotech to look at strategic ...
Vivoryon Therapeutics’ glutaminyl cyclase inhibitor has failed a second phase 2 Alzheimer’s disease study this year, leaving the German biotech trying to find a silver lining in the drug’s potential ...
Two gamers have shown off a hilarious Call of Duty: Warzone 2 fail, each from their own perspective of events. It can be difficult to win matches in Call of Duty: Warzone 2, and one of these players ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback